CAMBRIDGE, Mass., June 23, 2025--Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on developing and commercializing apitegromab for patients with spinal muscular atrophy ...

34th Seoul Music Awards 2025 Full Winners List With Names: BTS RM and Jimin win their first award post military discharge. Heres who won what at the SMA 2025.

The Universiti Pendidikan Sultan Idris (UPSI) began in 1922, but gained its current name in 1997 when it was officially established as a university. The university is located in Tanjong Malim, ...

US President Donald Trump has attracted criticism from some Catholics after posting an AI-generated image of himself as the Pope. The picture, which was shared by official White House social media ...

SonicWall confirms wild exploitation of CVE-2023-44221 and CVE-2024-38475 in SMA100 devices, risking file access and session hijacking.

Soft actuators driven by shape memory alloy (SMA) wires are capable of undergoing a large deformation and offering a fast response, which allows them to assemble soft robots for diverse operations.

A remote code execution vulnerability affecting SonicWall Secure Mobile Access (SMA) appliances has been under active exploitation since at least January 2025, according to cybersecurity company ...

Spinal muscular atrophy (SMA) is a disorder affecting the motor neurons—nerve cells that control voluntary muscle movement. These cells are located in the spinal cord. Because the muscles cannot ...

Insurance denials for SMA treatments are common, particularly with employer-based insurance, leading to treatment delays and increased financial burdens. SHOW MORE ...

Vincent Gaynor remembers, almost to the minute, when he realized his part in birthing the breakthrough gene therapy Zolgensma had ended and the forces that turned it into the world’s most ...

Ad hoc announcement pursuant to Art. 53 LR The Phase III STEER study met its primary endpoint showing an increase from baseline in HFMSE total score in patients with SMA treated with intrathecal ...

A phase 3 trial of Biohaven’s taldefgrobep alfa in spinal muscular atrophy (SMA) has missed its primary endpoint. The biotech plans to talk to the FDA about the next steps in SMA and is stepping ...